Effects of autoimmune antibodies anti-lipoprotein lipase, anti-low density lipoprotein, and anti-oxidized low density lipoprotein on lipid metabolism and atherosclerosis in systemic lupus erythematosus

Revista Brasileira de Reumatologia

Volumn 50, Issue 5, 2010, Pages 545-551

  Fesmire, James ^a   Wolfson Reichlin, Marianne ^a   Reichlin, Morris ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Dyslipidemia; Lipoprotein lipase; Systemic lupus erythematosus; Triglycerides

Indexed keywords

AUTOANTIBODY; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE ANTIBODY; LOW DENSITY LIPOPROTEIN ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY RISK; ECHOGRAPHY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PREDICTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ATHEROSCLEROSIS; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; AUTOANTIBODIES; FEMALE; HUMANS; LIPID METABOLISM; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 78649573294     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Reichlin M, Fesmire J, Quintero-Del-Rio AI, Wolfson-Reichlin M. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus. Arthritis Rheum 2002; 46:2957-63.
2. de Carvalho JF, Borba EF, Viana VST, Bueno C, Leon EP, Bonfá E. Anti-Lipoprotein Lipase Antibodies. Arthritis Rheum 2004; 50(11):3610-5.
3. de Carvalho JF, Viana VST, Neto EFB, Leon EP, Bueno C, Bonfá E. Longitudinal fluctuation of anti-lipoprotein lipase antibody is related with disease activity in systemic lupus erythematosus patients without anti-dsDNA antibodies. Rev. Bras. Reumatol 2009; 49(1):39-47.
4. Kodera M, Hayakawa I, Komura K, Yanaba K, Hasegawa M, Takehara K et al. Anti-lipoprotein lipase antibody in systemic sclerosis: Association with elevated serum triglyceride concentrations. J Rheumatol 2005; 32(4):629-36.
5. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298:299-308.
6. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK et al. Relation of triglyceride metabolism and coronary artery disease, studies in the postprandial state. Arterioscler Thromb 1992; 12(11):1336-45.
7. März W, Scharnagl H, Winkler K, Tiran A, Nauck M. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules and angiographic coronary artery disease: The Ludwig Shafen Risk and Cardiovascular Health Study. Circulation 2004; 110: 3068-3074.
8. Zanolla CN, Franceschini L, Cacici G, De Cristan B, Arieti M, Vassanelli C. Usefulness of ultrasonographic markers of carotid atherosclerosis (intima-media thickness, unstable carotid plaques and severe carotid stenosis) for predicting presence and extent of coronary artery disease. J Cardiovasc Med 2009; 10(12):906-12.
9. Johnsen SH, Mathiesen EB. Carotid plaque compared with intimamedial thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep 2009; 11(1):21-7.
10. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The revised criteria for the classification of systemic lupus erytematosus. Arth Rheum 1982; 25:1271-7.
11. Lipid Research Clinics Program. Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. Second Edition, Bethesda, MD: National Heart, Lung and Blood Institute, NIH, U.S. Dept. of Health and Human Services, 1982.
12. Lee DM, Downs D. A quick and large-scale density gradient subfractionation method for low density lipoproteins. J Lipid Res 1982; 23(1):14-27.
13. Palinski W, Ylä-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990; 10(3):325-35.
14. Havel RJ, Eder HA, Bradgon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34(9):1345-53.
15. Blackett PR, Kittredge D. Hyperlipidemia in children. South Med J 1993; 86:1083-92.
16. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6):499-502.
17. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990; 36(1):15-9.
18. Borbá EF, Bonfá E. Dyslipoproteinemias in systemic lupus erythematosus: Influence of disease activity and anticardiolipin antibodies. Lupus 1997; 6:533-9.